| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2005 | CN1212393C Gene engineering strain M1033WZ expression M1033GI mutation enzyme GIG138P and construction method thereof |
| 07/27/2005 | CN1212337C Tumour nascent blood ressel specificity conjugated polypeptide and human alpha interferon fusion protein and preparation |
| 07/27/2005 | CN1212336C Prepn. of recombinant human parathyroid hormone PTH(1-34) |
| 07/27/2005 | CN1212334C Human siali acid conjugated immunoglobulin-like agglutinant, its coding sequence and use |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/27/2005 | CA2555509A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer |
| 07/27/2005 | CA2525582A1 Synthetic nucleic acids from aquatic species |
| 07/26/2005 | US6921849 Dwarfism genes and dwarf plants |
| 07/26/2005 | US6921848 Genes involved in brassinosteroid hormone action in plants |
| 07/26/2005 | US6921845 Using tumor suppressor mutants for screening modulators and/or treatment of long term memory defects and anxiety; learning enhancement |
| 07/26/2005 | US6921816 Supplying nucleic acids into cell organelles |
| 07/26/2005 | US6921815 Controlling gene expression; plants |
| 07/26/2005 | US6921813 Comprises subunit of RNA polymerase holoenzyme which confers promoter sequence recognition and initiation of transcription for designing drugs to prevent mycobacterium infections; gene expression inhibition |
| 07/26/2005 | US6921812 Increasing the binding of oligomeric compounds to proteins, e.g.,human serum albumin, and oligomeric high binding affinity to target RNA by using 2'-O-(2-Methylthioethyl) modified oligonucleotides; antisense drugs; enzyme resistance |
| 07/26/2005 | US6921809 Immunoglobulin conjugate comprising amino acid sequences from dihydrolipoamide dehydrogenase (P64K) for use as tool in immunodetection of heterologous protein expression; vaccine development |
| 07/26/2005 | US6921666 Methods for generating hypermutable yeast |
| 07/26/2005 | US6921665 Generation of differentiaed cells; obtain stem cells, transform with vector coding preferential proteins and reporter molecules, deplete undifferentiated stem cells from culture pool, recover differentiated cells |
| 07/26/2005 | US6921664 Telomerase |
| 07/26/2005 | US6921663 Adenovirus vector |
| 07/26/2005 | US6921659 Gram-negative bacterial cell deficient hydrolase/protease activity for use in generating uncleaved heterologously expressed polypeptides; somatotropins |
| 07/26/2005 | US6921658 Serine protease BSSP6 |
| 07/26/2005 | US6921657 Protease variants and compositions |
| 07/26/2005 | US6921656 Comprises heat resistant hydrolase for production of glucose, isomerized sugars, oligosaccharides, liquors and fermented alchol |
| 07/26/2005 | US6921655 Endoglucanases and cellulase preparations containing the same |
| 07/26/2005 | US6921651 Process for the preparation of amino acids by using coryneform bacteria with attenuated 1-phosphofructokinase activity |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/26/2005 | US6921646 DNA sequence comprising signal tranduction protein for monitoring cell regulation and morphological/embryonic development; drug screening |
| 07/26/2005 | US6921645 Antibodies to chemokine β-4 |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921642 Associating a primer with an analyte and subsequently using the primer to mediate rolling circle replication of a circular DNA molecule, amplification of DNA circle depend on the presence of primer, thus produces an amplifie signal |
| 07/26/2005 | US6921640 Labeling nucleotide sequences; obtain nucleotide sequences, incubate with primer, amplify, transcribe sequences, cleave sequences, incubate with label, recover labeled nucleotide sequences |
| 07/26/2005 | US6921639 Analyzing nucleotide sequences in sample; obtain sample liquid containing nucleotide sequences, insert into container, oscilate, detect nucleotide sequences |
| 07/26/2005 | US6921637 Liquid microarray; for use as diagnostic tools |
| 07/26/2005 | US6921634 Detecting viricidal compounds which inhibit duplication of RNA sequences; fusion proteins; antiproliferative agents |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | US6921534 Hepatitis B virus treatment |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/26/2005 | CA2373422C Protein nectin-3 |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/26/2005 | CA2240097C Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 07/26/2005 | CA2235131C A method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
| 07/26/2005 | CA2174632C Methods of screening for beta-amyloid peptide production inhibitors |
| 07/26/2005 | CA2173115C Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carnitine |
| 07/26/2005 | CA2076961C Igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use |
| 07/26/2005 | CA2005567C Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/22/2005 | CA2455659A1 Barhl2 proteins, genes encoding the same and uses thereof |
| 07/21/2005 | WO2005066628A1 Bioluminescent assays and cells useful therein |
| 07/21/2005 | WO2005066371A2 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 07/21/2005 | WO2005066365A1 Specific expression of ndrg2 gene in dendritic cells and detection of dendritic cells |
| 07/21/2005 | WO2005066364A1 Primer for nucleic acid amplification, primer set for nucleic acid amplification and method of cancer screening therewith |
| 07/21/2005 | WO2005066357A1 Method of screening molecule associated with psychiatric disorder |
| 07/21/2005 | WO2005066349A2 Genes encoding proteins with pesticidal activity |
| 07/21/2005 | WO2005066348A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | WO2005066347A1 Proteins |
| 07/21/2005 | WO2005066344A2 New plasmids, their derivatives and fragments, their methods of manufacture and application |
| 07/21/2005 | WO2005066343A1 Nucleic acid purification chip |
| 07/21/2005 | WO2005066333A1 Stabilizing compositions for recombinant viruses |
| 07/21/2005 | WO2005066208A2 Method for production of recombinant growth hormone in form of hybrid protein |
| 07/21/2005 | WO2005066202A2 Bacillus cry9 family members |
| 07/21/2005 | WO2005065720A1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 07/21/2005 | WO2005065719A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | WO2005065711A2 Mammalian receptor proteins; related reagents and methods |
| 07/21/2005 | WO2005065707A2 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof |
| 07/21/2005 | WO2005065703A1 Novel use of ligand to gpr103-like receptor protein |
| 07/21/2005 | WO2005065450A1 Transgenic bird and method of constructing the same |
| 07/21/2005 | WO2005065446A1 Method of producing sterile plant, plant obtained by using the same and use thereof |
| 07/21/2005 | WO2005065405A1 Membranes incorporating recognition moieties |
| 07/21/2005 | WO2005065348A2 Transactivation system for mammalian cells |
| 07/21/2005 | WO2005065339A2 Cell cycle genes and related methods of using |
| 07/21/2005 | WO2005065309A2 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer |
| 07/21/2005 | WO2005065268A2 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | WO2005065239A2 Novel recombinant proteins with n-terminal free thiol |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2005047473A3 Single vector dual gene therapy for pulmonary hypertension |
| 07/21/2005 | WO2005047455A3 Methods for the production of apolipoproteins in transgenic plants |
| 07/21/2005 | WO2005045039A9 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/21/2005 | WO2005042018A3 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/21/2005 | WO2005040186A3 Method for preparing a modified host cell |
| 07/21/2005 | WO2005037991A3 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 07/21/2005 | WO2005037226A3 Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders |
| 07/21/2005 | WO2005035547A3 E2f oligonucleotide decoy molecules |
| 07/21/2005 | WO2005028657A3 Excretable reporter systems |
| 07/21/2005 | WO2005026316A8 Alphavirus vaccines |
| 07/21/2005 | WO2005019460A3 Promoters for the expression of genes in tagetes |
| 07/21/2005 | WO2005016366A3 Method to inhibit the propagation of an undesired cell population |
| 07/21/2005 | WO2005015990A8 New diabetes type 2 animal model |
| 07/21/2005 | WO2005012351A3 Novel functions for decay accelerating factor (daf) in inflammation |
| 07/21/2005 | WO2005003313A3 Methods and compositions for enhanced protein expression and purification |
| 07/21/2005 | WO2004076481A3 Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus |
| 07/21/2005 | WO2004063339A3 G-quadruplex binding assays and compounds therefor |
| 07/21/2005 | WO2004060274A3 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells |
| 07/21/2005 | WO2004039941A3 METHODS OF SCREENING FOR TRPM4b MODULATORS |
| 07/21/2005 | WO2004029197A8 Co-stimulatory molecules |
| 07/21/2005 | WO2004024064A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | WO2004011665A3 Methods for fragmentation, labeling and immobilization of nucleic acids |
| 07/21/2005 | WO2003106693A3 Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof |
| 07/21/2005 | WO2003057160A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/21/2005 | US20050160503 Transgenic seeds which generate diseaase, herbicide and insect resistant plants; enhanced storage stability; improving crop plants |
| 07/21/2005 | US20050160502 Using surgical insertion and electroporation to generate bioreactor for heterologous gene expression; gene transfer constructs |
| 07/21/2005 | US20050160501 Chloroplast transformation and expression of osmoprotectants |